Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:18:19 EST Fri 06 Feb 2026
Enter Symbol
or Name
USA
CA



V:NXG - NexgenRx Inc. - https://www.nexgenrx.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NXG - V30.00.32·0.371.00.3850.051    0.45  0.24Feb 04Dec 1115 min RT 2¢

Recent Trades - All 1 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-12-11 16:37C:NXG0.42Dividend DeclaredNexgenRx to pay 0.5-cent dividend Dec. 19
2025-12-10 20:26C:NXG0.42News ReleaseNexgenRx Announces Declaration of Divdends
2025-11-20 19:55C:NXG0.41News ReleaseNexgenRx Announces Significant Third Quarter Revenue and EBITDA Growth
2025-11-20 12:46C:NXG0.41SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-20 12:40C:NXG0.41SEDAR Interim MD & ASEDAR Interim MD & A
2025-08-18 21:23C:NXG0.37Dividend DeclaredNexgenRx to pay 0.5-cent dividend Aug. 29
2025-08-15 16:30C:NXG0.37News ReleaseNexgenRx Announces Declaration of Dividend
2025-08-12 23:30C:NXG0.37News ReleaseNexgenRx's Q2 2025 revenue at $4.34-million
2025-08-12 16:55C:NXG0.37SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-08-12 16:55C:NXG0.37SEDAR Interim MD & ASEDAR Interim MD & A
2025-05-15 14:32C:NXG0.29News ReleaseNexgenRx Announces First Quarter Results With Solid Revenue Growth and Positive EBITDA
2025-05-15 14:13C:NXG0.29SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-05-15 14:13C:NXG0.29SEDAR Interim MD & ASEDAR Interim MD & A
2025-04-21 16:29C:NXG0.295Dividend DeclaredNexgenRx to pay 0.5-cent dividend April 30
2025-04-17 20:02C:NXG0.295News ReleaseNexgenRx to pay 0.5-cent dividend April 30
2025-04-03 18:06C:NXG0.25News ReleaseNexgenRx Announces 2024 Year End Results with Continued Strong Revenue Growth and Increasing Positive EBITDA
2025-04-03 16:52C:NXG0.25SEDAR MD & ASEDAR MD & A
2025-04-03 16:46C:NXG0.25SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements